Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
Kato H, Maezawa Y, Nishijima D, Iwamoto E, Takeda J, Kanamori T, Yamaga M, Mishina T, Takeda Y, Izumi S, Hino Y, Nishi H, Ishiko J, Takeuchi M, Kaneko H, Koshizaka M, Mimura N, Kuzuya M, Sakaida E, Takemoto M, Shiraishi Y, Miyano S, Ogawa S, Iwama A, Sanada M, Yokote K. Kato H, et al. Among authors: hino y. Exp Hematol. 2022 May;109:11-17. doi: 10.1016/j.exphem.2022.02.005. Epub 2022 Feb 28. Exp Hematol. 2022. PMID: 35240258 Free article.
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis.
Takaishi K, Tsukamoto S, Ohwada C, Takeuchi M, Kawasaki Y, Nagai Y, Mishina T, Yamazaki M, Isshiki Y, Kayamori K, Kimura K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Iseki T, Nakaseko C, Sakaida E. Takaishi K, et al. Among authors: hino y. J Thromb Thrombolysis. 2019 Jul;48(1):141-148. doi: 10.1007/s11239-019-01809-w. J Thromb Thrombolysis. 2019. PMID: 30673940
T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia.
Kimura K, Tsukamoto S, Takaishi K, Isshiki Y, Kayamori K, Hino Y, Ohshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Iseki T, Nakaseko C, Sakaida E. Kimura K, et al. Among authors: hino y. Leuk Lymphoma. 2019 Jun;60(6):1591-1594. doi: 10.1080/10428194.2018.1548704. Epub 2019 Jan 16. Leuk Lymphoma. 2019. PMID: 31161870 No abstract available.
Remarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemia.
Nagai Y, Tsukamoto S, Hino Y, Isshiki Y, Yamazaki M, Izumi S, Mishina T, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Takeuchi M, Iseki T, Nakaseko C, Sakaida E. Nagai Y, et al. Among authors: hino y. Leuk Lymphoma. 2020 Jan;61(1):221-224. doi: 10.1080/10428194.2019.1660973. Epub 2019 Sep 5. Leuk Lymphoma. 2020. PMID: 31486335 No abstract available.
Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells.
Takaishi K, Takeuchi M, Tsukamoto S, Takayama N, Oshima M, Kimura K, Isshiki Y, Kayamori K, Hino Y, Oshima-Hasegawa N, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Iseki T, Nakamura S, Eto K, Iwama A, Yokote K, Nakaseko C, Sakaida E. Takaishi K, et al. Among authors: hino y. Haematologica. 2020 May;105(5):e216-e220. doi: 10.3324/haematol.2018.214841. Epub 2019 Sep 5. Haematologica. 2020. PMID: 31488559 Free PMC article. No abstract available.
Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome.
Shibamiya A, Ohwada C, Ishii A, Mishina T, Nagai Y, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Tsukamoto S, Takeda Y, Mitsukawa S, Mimura N, Iseki T, Misawa S, Kuwabara S, Nakaseko C, Sakaida E. Shibamiya A, et al. Among authors: hino y. Bone Marrow Transplant. 2021 Feb;56(2):517-520. doi: 10.1038/s41409-020-01024-9. Epub 2020 Aug 10. Bone Marrow Transplant. 2021. PMID: 32778687 No abstract available.
Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine.
Kikuchi T, Mori T, Ohwada C, Onoda M, Shimizu H, Yokoyama H, Onizuka M, Koda Y, Kato J, Takeda Y, Hino Y, Mishina T, Sakaida E, Shono K, Nagao Y, Yokota A, Matsumoto K, Morita K, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Kikuchi T, et al. Among authors: hino y. Int J Hematol. 2021 Jan;113(1):128-133. doi: 10.1007/s12185-020-02990-y. Epub 2020 Sep 4. Int J Hematol. 2021. PMID: 32886279
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.
Mishina T, Oshima-Hasegawa N, Tsukamoto S, Fukuyo M, Kageyama H, Muto T, Mimura N, Rahmutulla B, Nagai Y, Kayamori K, Hino Y, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Tsujimura H, Iseki T, Nakaseko C, Ikeda JI, Itami M, Yokote K, Ohara O, Kaneda A, Sakaida E. Mishina T, et al. Among authors: hino y. Br J Haematol. 2021 Dec;195(5):731-742. doi: 10.1111/bjh.17765. Epub 2021 Aug 10. Br J Haematol. 2021. PMID: 34378195
Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation.
Ohwada C, Yamazaki S, Shono K, Kayamori K, Hino Y, Oshima-Hasegawa N, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Iseki T, Onoda M, Yokota A, Suzuki T, Ishii I, Nakaseko C, Sakaida E. Ohwada C, et al. Among authors: hino y. Int J Hematol. 2021 Dec;114(6):664-673. doi: 10.1007/s12185-021-03188-6. Epub 2021 Sep 14. Int J Hematol. 2021. PMID: 34523110
294 results